The introduction of nicotinamide like a nicotine substitute in e-cigarette and smokeless products and solutions represents an important regulatory obstacle for that FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to work as a sedative at substantial dosages6. The promises made by Nicotine River, ECBlend, and var